# Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)

> **NCT06463132** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Rion Inc.** · enrollment: 24 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **COMBINATION_PRODUCT:** PEP/Euflexxa
- **DRUG:** PEP

## Key facts

- **NCT ID:** NCT06463132
- **Lead sponsor:** Rion Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06463132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06463132, "Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06463132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*